Our studies confirm that cardiac SGLT1 is upregulated both in human subjects with type 2 diabetes and diabetic cardiomyopathy and in murine models of diabetic cardiomyopathy. This evidence concerns the gene SLC5A1 and type 2 diabetes mellitus.